Ligne de temps
01 août 2021
18 févr. 2019
publication
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
Lire plus12 févr. 2019
03 avr. 2018
publication
Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.
Lire plus06 sept. 2017
publication
An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms
Lire plus30 août 2017
publication
Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder.
Lire plus30 mars 2017
19 janv. 2017
06 déc. 2016
publication
Immunological and Antiviral Responses After Therapeutic DNA Immunization in Chronic Hepatitis B Patients Efficiently Treated by Analogues
Lire plus24 nov. 2016
publication
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection
Lire plus15 nov. 2016
publication
Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial
Lire plus01 nov. 2016
publication
Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
Lire plus22 oct. 2016
publication
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
Lire plus17 oct. 2016
publication
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study
Lire plus13 oct. 2016
publication
Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo
Lire plus04 oct. 2016
publication
Diagnostic accuracy of des-gamma-carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse(®) G600 analyzer
Lire plus01 oct. 2016
15 sept. 2016
publication
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Lire plus10 sept. 2016
publication
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Lire plus07 sept. 2016
07 sept. 2016
publication
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Lire plus17 août 2016
publication
BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease
Lire plus09 août 2016
publication
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
Lire plus04 août 2016
publication
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)
Lire plus01 août 2016
publication
High Prevalence of Antimicrobial-resistant Gram-negative Colonization in Hospitalized Cambodian Infants
Lire plus29 juil. 2016
publication
Reply to “A strong message is needed to address the issue of HCC recurrence after DAA therapy”
Lire plus29 juil. 2016
publication
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients
Lire plus28 juil. 2016
publication
Anti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices model
Lire plus19 juil. 2016
publication
Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis
Lire plus12 juil. 2016
publication
The relationship between liver stiffness measurement and outcome in patients with chronic hepatitis C and cirrhosis: a retrospective longitudinal hospital study
Lire plus24 juin 2016
publication
Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin
Lire plus23 juin 2016
publication
Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration
Lire plus03 juin 2016
publication
In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas
Lire plus04 mai 2016
publication
Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case
Lire plus22 avr. 2016
publication
Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis
Lire plus28 mars 2016
publication
Comprehensive review of telbivudine in pregnant women with chronic hepatitis B
Lire plus22 mars 2016
publication
An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO Guidelines
Lire plus18 mars 2016
04 mars 2016
publication
Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life
Lire plus04 mars 2016
publication
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)
Lire plus02 mars 2016
publication
Development and internal validation of a multivariable prediction model for biochemical failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer
Lire plus01 mars 2016
publication
Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus
Lire plus01 mars 2016
20 févr. 2016
publication
Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France
Lire plus17 févr. 2016
publication
Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy
Lire plus30 janv. 2016
publication
Mycobacterium avium complex disseminated infection in a kidney transplant recipient
Lire plus01 janv. 2016
01 janv. 2016
publication
Idiopathic gingival fibromatosis with asymmetrical presentation and electrosurgical management
Lire plus08 déc. 2015
04 déc. 2015
publication
Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions
Lire plus23 nov. 2015
publication
Acid Sphingomyelinase-Derived Ceramide Regulates ICAM-1 Function during T Cell Transmigration across Brain Endothelial Cells
Lire plus21 nov. 2015
17 nov. 2015
16 nov. 2015
13 nov. 2015
publication
Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study
Lire plus05 nov. 2015
01 nov. 2015
publication
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies
Lire plus28 oct. 2015
publication
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)
Lire plus22 oct. 2015
08 oct. 2015
publication
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
Lire plus05 oct. 2015
publication
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
Lire plus28 sept. 2015
publication
[Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure]
Lire plus15 sept. 2015
publication
Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging
Lire plus15 sept. 2015
publication
Acceptance and commitment therapy group-treatment for non-responsive patients with personality disorders: An exploratory study
Lire plus10 sept. 2015
07 sept. 2015
publication
[Treatment of chronic hepatitis B virus infection and hepatocellular carcinoma prevention]
Lire plus05 sept. 2015
publication
Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints
Lire plus01 sept. 2015
publication
Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?
Lire plus06 août 2015
publication
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial
Lire plus03 août 2015
publication
Enhanced microglial pro-inflammatory response to lipopolysaccharide correlates with brain infiltration and blood-brain barrier dysregulation in a mouse model of telomere shortening
Lire plus27 juil. 2015
publication
The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients
Lire plus25 juil. 2015
publication
Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosis
Lire plus29 juin 2015
publication
Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration
Lire plus24 juin 2015
publication
The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study
Lire plus19 juin 2015
publication
Patients with chronic hepatitis B should be screened for hepatocellular carcinoma regardless of liver stiffness measurement
Lire plus20 mai 2015
publication
Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed
Lire plus14 mai 2015
publication
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study
Lire plus09 mai 2015
publication
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
Lire plus05 mai 2015
publication
Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection
Lire plus09 avr. 2015
publication
Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatment
Lire plus31 mars 2015
publication
Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
Lire plus27 mars 2015
publication
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling
Lire plus20 mars 2015
publication
Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
Lire plus13 mars 2015
publication
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Lire plus25 févr. 2015
publication
Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair
Lire plus25 févr. 2015
publication
Long-term stability and temporal trends of organic contaminants in four collections of mussel tissue frozen standard reference materials
Lire plus19 févr. 2015
publication
Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders
Lire plus17 févr. 2015
23 janv. 2015
publication
IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple sclerosis
Lire plus23 janv. 2015
publication
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy
Lire plus22 janv. 2015
publication
Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study
Lire plus06 janv. 2015
publication
Telaprevir enhances ribavirin-induced anaemia through renal function impairment
Lire plus17 déc. 2014
publication
Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation
Lire plus16 déc. 2014
publication
Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?
Lire plus10 déc. 2014
publication
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis
Lire plus24 nov. 2014
publication
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study
Lire plus21 nov. 2014
publication
Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection
Lire plus21 nov. 2014
publication
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
Lire plus11 nov. 2014
publication
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
Lire plus11 nov. 2014
publication
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study
Lire plus10 nov. 2014
publication
Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection
Lire plus26 oct. 2014
publication
Persistence to Treatment of Chronic Hepatitis B Virus (Hbv) Infection: A Study Based on the French Ims Lifelink Treatment Dynamics (LTD) Database
Lire plus16 oct. 2014
publication
Urinary antibiotic activity in paediatric patients attending an outpatient department in north-western Cambodia
Lire plus13 oct. 2014
publication
Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection
Lire plus01 oct. 2014
publication
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection.
Lire plus22 sept. 2014
publication
Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography
Lire plus18 sept. 2014
publication
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin
Lire plus11 sept. 2014
03 sept. 2014
publication
Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir
Lire plus28 août 2014
23 août 2014
publication
Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis
Lire plus18 août 2014
publication
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial
Lire plus15 août 2014
publication
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis
Lire plus30 juil. 2014
publication
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
Lire plus28 juil. 2014
publication
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
Lire plus16 juil. 2014
publication
Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C
Lire plus01 juil. 2014
publication
Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal
Lire plus30 juin 2014
publication
Transcription factor induction of human oligodendrocyte progenitor fate and differentiation
Lire plus02 juin 2014
publication
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study
Lire plus28 mai 2014
publication
All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection
Lire plus04 mai 2014
01 mai 2014
22 avr. 2014
publication
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis
Lire plus03 avr. 2014
publication
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis
Lire plus01 avr. 2014
publication
Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions
Lire plus20 mars 2014
19 mars 2014
publication
Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection
Lire plus17 mars 2014
publication
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
Lire plus03 mars 2014
20 févr. 2014
publication
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial–ANRS HB02 VAC-ADN
Lire plus07 févr. 2014
publication
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt
Lire plus01 févr. 2014
01 févr. 2014
16 janv. 2014
publication
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma
Lire plus27 déc. 2013
publication
Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response
Lire plus20 déc. 2013
publication
Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation
Lire plus15 déc. 2013
publication
Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries
Lire plus05 déc. 2013
publication
Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues
Lire plus25 nov. 2013
publication
Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1
Lire plus20 nov. 2013
01 nov. 2013
01 nov. 2013
30 oct. 2013
publication
Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection
Lire plus26 oct. 2013
publication
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders
Lire plus17 oct. 2013
17 oct. 2013
publication
Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial
Lire plus16 oct. 2013
publication
Improved fibrosis staging by elastometry and blood test in chronic hepatitis C
Lire plus15 oct. 2013
publication
ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy
Lire plus20 sept. 2013
03 sept. 2013
01 sept. 2013
publication
Kinetic profiles and management of hepatitis B virus reactivation in patients with immune-mediated inflammatory diseases
Lire plus09 août 2013
08 août 2013
publication
AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations
Lire plus06 août 2013
26 juin 2013
publication
PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients
Lire plus26 juin 2013
publication
Randomized study of asunaprevir plus pegylated interferon-α and ribavirin for previously untreated genotype 1 chronic hepatitis C
Lire plus12 juin 2013
publication
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial
Lire plus11 juin 2013
publication
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study)
Lire plus01 juin 2013
01 juin 2013
publication
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial
Lire plus01 juin 2013
publication
Rapid progression of antiviral treatments of chronic hepatitis C virus infection
Lire plus17 mai 2013
publication
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C
Lire plus10 mai 2013
publication
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
Lire plus30 avr. 2013
publication
CD133/CD140a-based isolation of distinct human multipotent neural progenitor cells and oligodendrocyte progenitor cells
Lire plus20 avr. 2013
publication
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24
Lire plus10 avr. 2013
publication
Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study
Lire plus04 avr. 2013
publication
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results
Lire plus21 mars 2013
16 mars 2013
21 févr. 2013
04 févr. 2013
publication
Determination of reliability criteria for liver stiffness evaluation by transient elastography
Lire plus01 févr. 2013
01 févr. 2013
12 janv. 2013
publication
Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure
Lire plus02 déc. 2012
publication
Reply to: “Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection”
Lire plus23 nov. 2012
publication
Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure
Lire plus05 nov. 2012
publication
Clinical management of drug-drug interactions in HCV therapy: challenges and solutions
Lire plus27 sept. 2012
publication
Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy
Lire plus28 août 2012
23 août 2012
publication
Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation
Lire plus14 août 2012
publication
Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver
Lire plus27 juil. 2012
publication
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection
Lire plus12 juil. 2012
publication
Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection
Lire plus03 juil. 2012
02 juil. 2012
publication
Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation
Lire plus23 juin 2012
publication
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation
Lire plus20 juin 2012
publication
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier
Lire plus18 juin 2012
publication
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
Lire plus02 juin 2012
01 juin 2012
01 juin 2012
publication
Severe skin rash in case of readministration of telaprevir in a patient who previously experienced a non severe rash
Lire plus30 mai 2012
publication
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma
Lire plus21 mai 2012
publication
Factors that predict response of patients with hepatitis C virus infection to boceprevir
Lire plus03 mai 2012
publication
Nanoclusters of iron oxide: effect of core composition on structure, biocompatibility, and cell labeling efficacy
Lire plus19 avr. 2012
publication
T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO
Lire plus05 avr. 2012
publication
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation
Lire plus28 mars 2012
publication
First-line treatment of chronic hepatitis B with entecavir or tenofovir in ‘real-life’ settings: from clinical trials to clinical practice
Lire plus28 mars 2012
publication
Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection
Lire plus20 mars 2012
publication
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
Lire plus17 mars 2012
publication
Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib
Lire plus15 mars 2012
10 mars 2012
publication
Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection
Lire plus08 mars 2012
publication
Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers
Lire plus01 févr. 2012
publication
IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?
Lire plus30 janv. 2012
25 janv. 2012
publication
Dietary intake of plant sterols stably increases plant sterol levels in the murine brain
Lire plus13 janv. 2012
publication
Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C
Lire plus04 janv. 2012
publication
Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response
Lire plus01 janv. 2012
publication
Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive
Lire plus01 janv. 2012
publication
Discrimination of agonist and antagonist forms of CXCL10 in biological samples
Lire plus01 janv. 2012
01 janv. 2012
publication
Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?
Lire plus22 déc. 2011
publication
Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study
Lire plus19 déc. 2011
publication
Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir)
Lire plus16 déc. 2011
publication
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes
Lire plus09 déc. 2011
05 déc. 2011
publication
[New developments in ultrasound imaging for chronic liver diseases: from anatomic imaging to structural and functional imaging]
Lire plus01 déc. 2011
publication
Antiviral activity of telaprevir and boceprevir for the treatment of hepatitis C virus infection in treatment-experienced patients
Lire plus01 déc. 2011
publication
A true revolution: enhanced motivation of the patient with rapid loss of virus (or rapid negativation of viral load), relationship between viral and histological cure
Lire plus26 nov. 2011
publication
CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients
Lire plus06 nov. 2011
03 nov. 2011
publication
The role of adherence in virological suppression in patients receiving anti-HBV analogues
Lire plus01 nov. 2011
publication
Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib?
Lire plus09 oct. 2011
publication
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases
Lire plus19 sept. 2011
publication
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis
Lire plus16 sept. 2011
publication
Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection
Lire plus01 sept. 2011
publication
[Management of the risk of hepatitis B virus reactivation in patients receiving immunosuppressive and immunomodulatory agents in internal medicine: data from the REACTI-B survey and proposal for a management algorithm]
Lire plus12 août 2011
publication
Brain endothelial barrier passage by monocytes is controlled by the endothelin system
Lire plus20 juil. 2011
publication
Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients
Lire plus20 juil. 2011
19 juil. 2011
publication
Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients
Lire plus15 juil. 2011
publication
Current management and recommendations on hepatitis B therapy in HIV-coinfected patients
Lire plus14 juil. 2011
publication
Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6
Lire plus01 juil. 2011
publication
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Lire plus01 juil. 2011
publication
Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data
Lire plus23 juin 2011
23 juin 2011
11 juin 2011
25 mai 2011
publication
Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C
Lire plus18 mai 2011
publication
Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment
Lire plus01 mai 2011
13 avr. 2011
publication
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial
Lire plus06 avr. 2011
publication
Zirconium nanoparticles prepared by the reduction of zirconium oxide using the RAPET method
Lire plus05 avr. 2011
01 avr. 2011
publication
Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 haplotype
Lire plus26 mars 2011
publication
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
Lire plus21 févr. 2011
publication
Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers
Lire plus18 févr. 2011
publication
Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis
Lire plus14 févr. 2011
publication
Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib
Lire plus15 janv. 2011
01 janv. 2011
01 janv. 2011
01 janv. 2011
01 janv. 2011
22 déc. 2010
publication
Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis
Lire plus22 déc. 2010
publication
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
Lire plus08 déc. 2010
publication
Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesions
Lire plus11 nov. 2010
publication
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection
Lire plus09 nov. 2010
publication
Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study
Lire plus01 nov. 2010
publication
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients
Lire plus01 nov. 2010
publication
Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis
Lire plus26 oct. 2010
publication
Efficacy and pharmacokinetics of adefovir dipivoxil liquid suspension in patients with chronic hepatitis B and renal impairment
Lire plus01 oct. 2010
publication
Magnetic resonance imaging of monocytes labeled with ultrasmall superparamagnetic particles of iron oxide using magnetoelectroporation in an animal model of multiple sclerosis
Lire plus01 sept. 2010
30 août 2010
publication
Dry autoclaving for the nanofabrication of sulfides, selenides, borides, phosphides, nitrides, carbides, and oxides
Lire plus14 août 2010
04 août 2010
publication
Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study
Lire plus29 juin 2010
publication
Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection
Lire plus17 juin 2010
14 juin 2010
publication
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
Lire plus14 juin 2010
publication
Brief communication: case reports of ribavirin treatment for chronic hepatitis E
Lire plus27 avr. 2010
publication
Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009
Lire plus08 mars 2010
publication
HIV-associated obliterative portopathy (HIV-OP) underlies cryptogenic liver disease in HIV-seropositive patients
Lire plus01 mars 2010
18 janv. 2010
publication
Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination
Lire plus18 janv. 2010
publication
The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier
Lire plus13 janv. 2010
01 janv. 2010
publication
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells
Lire plus14 déc. 2009
10 déc. 2009
08 déc. 2009
02 déc. 2009
01 nov. 2009
publication
Evaluation of high performance liquid chromatography purified leptospiral antigen for the diagnosis of leptospirosis
Lire plus19 oct. 2009
publication
Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort
Lire plus05 oct. 2009
publication
Causes of death in HIV-infected women: persistent role of AIDS. The ‘Mortalité 2000 & 2005’ Surveys (ANRS EN19)
Lire plus01 oct. 2009
publication
Characterization of leptospires using V3 region of 16S rDNA by denaturing gradient gel electrophoresis: a case study
Lire plus01 sept. 2009
publication
Aspartate aminotransferase to platelet ratio index (APRI) score is inappropriate for assessment of liver fibrosis in HIV-infected patients with hazardous drinking
Lire plus01 sept. 2009
publication
Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4
Lire plus01 août 2009
publication
Human immunodeficiency virus-associated obliterative portopathy underlies unexplained aminotransferase elevations under antiretrovirals
Lire plus31 juil. 2009
publication
Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients
Lire plus01 juil. 2009
publication
Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin
Lire plus04 juin 2009
01 juin 2009
01 juin 2009
publication
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C
Lire plus27 mai 2009
publication
A sequence and structure based method to predict putative substrates, functions and regulatory networks of endo proteases
Lire plus01 mai 2009
publication
Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men
Lire plus30 avr. 2009
publication
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection
Lire plus09 avr. 2009
publication
Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice
Lire plus01 avr. 2009
publication
Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy
Lire plus26 mars 2009
publication
Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis
Lire plus01 mars 2009
01 mars 2009
01 mars 2009
01 mars 2009
01 mars 2009
publication
Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey
Lire plus06 févr. 2009
01 févr. 2009
publication
Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?
Lire plus01 févr. 2009
publication
Acute cholestatic hepatitis revealing Mycoplasma pneumoniae infection without lung involvement in an adult patient
Lire plus01 janv. 2009
publication
Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study – ANRS HC02
Lire plus01 janv. 2009
publication
Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study
Lire plus01 janv. 2009
publication
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment
Lire plus30 déc. 2008
publication
Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a
Lire plus17 nov. 2008
publication
The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B
Lire plus29 sept. 2008
publication
Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C
Lire plus20 sept. 2008
publication
A French prospective observational study of the treatment of chronic hepatitis C in drug abusers
Lire plus16 sept. 2008
publication
Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C
Lire plus15 sept. 2008
publication
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure
Lire plus01 sept. 2008
publication
Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier
Lire plus15 août 2008
publication
Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” surveys (ANRS EN19 and Mortavic)
Lire plus08 août 2008
01 août 2008
publication
A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients
Lire plus31 juil. 2008
publication
Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients
Lire plus17 juil. 2008
publication
Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy
Lire plus15 juil. 2008
publication
Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease
Lire plus11 juil. 2008
11 juil. 2008
publication
Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
Lire plus01 juil. 2008
28 juin 2008
19 juin 2008
publication
Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients
Lire plus11 juin 2008
publication
Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype
Lire plus10 juin 2008
publication
Effects of a 10 T external magnetic field on the thermal decomposition of Fe, Ni, and Co acetyl acetonates
Lire plus05 juin 2008
publication
Targeting the tetraspanin CD81 blocks monocyte transmigration and ameliorates EAE
Lire plus01 juin 2008
29 mai 2008
publication
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004
Lire plus01 mai 2008
publication
Erratum to ‘The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting’ [J. Clin. Virol. 41 (4) 2008 243-254]
Lire plus16 avr. 2008
01 avr. 2008
publication
Severe weight loss in HIV / HCV-coinfected patients treated with interferon plus ribavirin: incidence and risk factors
Lire plus26 mars 2008
12 mars 2008
publication
Sexually transmitted hepatitis C virus superinfection in HIV/hepatitis C virus co-infected men who have sex with men
Lire plus01 mars 2008
publication
Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors
Lire plus01 mars 2008
01 mars 2008
01 mars 2008
01 mars 2008
01 mars 2008
publication
Response to Schiano et al. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV
Lire plus14 févr. 2008
publication
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study–ANRS HC02
Lire plus01 févr. 2008
publication
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
Lire plus18 janv. 2008
publication
The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting
Lire plus01 janv. 2008
publication
[Chronic hepatitis B: unusual situations: dialysis, renal transplantation and pre-emptive therapy in immune compromised patients]
Lire plus14 nov. 2007
publication
MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO
Lire plus14 nov. 2007
publication
Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin
Lire plus02 oct. 2007
publication
Treatment of hepatitis C virus in human immunodeficiency virus infected patients in “real life”: modifications in two large surveys between 2004 and 2006
Lire plus01 oct. 2007
publication
[Liver and antiretrovirals: hepatotoxicity, steatosis and monitoring of patients with liver disease]
Lire plus01 oct. 2007
publication
[A puzzling case of portal hypertension in a patient with human immunodeficiency and hepatitis C virus co-infection]
Lire plus01 oct. 2007
01 oct. 2007
publication
Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosis
Lire plus01 sept. 2007
publication
Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
Lire plus01 août 2007
31 juil. 2007
publication
High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
Lire plus19 juil. 2007
01 juil. 2007
publication
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest
Lire plus22 juin 2007
publication
Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling
Lire plus19 juin 2007
publication
Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)
Lire plus31 mai 2007
publication
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel
Lire plus08 mai 2007
publication
External magnetic field-induced mesoscopic organization of Fe3O4 pyramids and carbon sheets
Lire plus01 mai 2007
publication
Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope
Lire plus01 mai 2007
publication
Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?
Lire plus01 mai 2007
publication
Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function
Lire plus15 mars 2007
publication
Rapid and early virological response to chronic hepatitis C treatment with IFN alpha2b or PEG-IFN alpha2b plus ribavirin in HIV/HCV co-infected patients
Lire plus01 mars 2007
01 mars 2007
publication
Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)
Lire plus01 févr. 2007
publication
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study
Lire plus11 janv. 2007
publication
Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients
Lire plus01 janv. 2007
publication
Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C
Lire plus01 janv. 2007
01 janv. 2007
publication
The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands
Lire plus01 déc. 2006
publication
Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection
Lire plus25 oct. 2006
publication
Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells
Lire plus01 oct. 2006
01 oct. 2006
01 oct. 2006
publication
[Impact of resistance to analogue antivirals and therapeutic strategies in situations of dialysis, kidney transplantation, vasculitis, and preemptive treatments in immunosuppressed patients]
Lire plus01 oct. 2006
publication
Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life
Lire plus25 sept. 2006
01 sept. 2006
publication
FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients
Lire plus01 sept. 2006
27 août 2006
15 août 2006
publication
Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity
Lire plus25 juil. 2006
publication
Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study
Lire plus13 juil. 2006
publication
Synthesis of a conducting SiO2-carbon composite from commercial silicone grease and its conversion to paramagnetic SiO2 particles
Lire plus01 juil. 2006
publication
[Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study]
Lire plus15 juin 2006
publication
Thermal decomposition of commercial silicone oil to produce high yield high surface area SiC nanorods
Lire plus01 mai 2006
publication
Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status
Lire plus01 avr. 2006
28 févr. 2006
01 févr. 2006
01 févr. 2006
publication
Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin
Lire plus26 janv. 2006
publication
Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor
Lire plus17 janv. 2006
publication
Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d’Etude des Lymphomes de l’Adulte programs
Lire plus01 janv. 2006
publication
Optimizing treatment outcomes in chronic hepatitis C: management of non-response
Lire plus01 janv. 2006
publication
Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy
Lire plus26 déc. 2005
publication
Synthesis of WO3 nanorods by reacting WO(OMe)4 under autogenic pressure at elevated temperature followed by annealing
Lire plus15 déc. 2005
publication
Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus
Lire plus21 nov. 2005
publication
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection
Lire plus11 nov. 2005
publication
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment
Lire plus04 nov. 2005
publication
Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin
Lire plus27 oct. 2005
publication
Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency
Lire plus06 oct. 2005
publication
Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study
Lire plus30 sept. 2005
publication
The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients
Lire plus30 sept. 2005
16 sept. 2005
publication
The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy
Lire plus01 sept. 2005
publication
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy
Lire plus18 août 2005
publication
Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers
Lire plus01 juil. 2005
publication
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study
Lire plus28 juin 2005
19 mai 2005
publication
Fabrication and magnetic properties of Ni nanospheres encapsulated in a fullerene-like carbon
Lire plus01 mai 2005
publication
Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004
Lire plus14 avr. 2005
07 avr. 2005
publication
Applied magnetic field rejects the coating of ferromagnetic carbon from the surface of ferromagnetic cobalt: RAPET of CoZr2(acac)2(OiPr)8
Lire plus01 avr. 2005
31 mars 2005
01 févr. 2005
publication
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection
Lire plus21 janv. 2005
publication
[Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection: epidemiology, severity and recent therapeutic strategies]
Lire plus01 janv. 2005
publication
The impact of haematopoietic growth factors on the management and efficacy of antiviral treatment in patients with hepatitis C virus
Lire plus01 janv. 2005
20 déc. 2004
publication
Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus
Lire plus20 déc. 2004
publication
Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis
Lire plus15 déc. 2004
publication
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial
Lire plus01 nov. 2004
publication
Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis
Lire plus01 nov. 2004
01 oct. 2004
01 oct. 2004
publication
Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers
Lire plus27 sept. 2004
publication
Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C
Lire plus20 sept. 2004
publication
Reactions under autogenic pressure at elevated temperature (RAPET) of various alkoxides: formation of metals/metal oxides-carbon core-shell structures
Lire plus01 juil. 2004
publication
Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment
Lire plus20 mai 2004
publication
The Effect of a Magnetic Field on a RAPET (Reaction under Autogenic Pressure at Elevated Temperature) of MoO(OMe)(4): Fabrication of MoO(2) Nanoparticles Coated with Carbon or Separated MoO(2) and Carbon Particles
Lire plus01 mai 2004
publication
[The role of contrast-enhanced ultrasonography for the detection of hepatocellular carcinoma]
Lire plus01 avr. 2004
publication
Intrahepatic hepatitis C virus RNA quantification in microdissected hepatocytes
Lire plus01 mars 2004
publication
Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer
Lire plus01 mars 2004
publication
Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C
Lire plus01 mars 2004
publication
HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms
Lire plus16 janv. 2004
publication
Surprisingly stable helical conformations in alpha/beta-peptides by incorporation of cis-beta-aminocyclopropane carboxylic acids
Lire plus01 janv. 2004
01 janv. 2004
01 janv. 2004
publication
Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy
Lire plus22 déc. 2003
publication
Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study
Lire plus01 déc. 2003
publication
[Nucleoside analogues resistance in the treatment of chronic hepatitis B virus infection]
Lire plus21 nov. 2003
15 août 2003
publication
Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)
Lire plus01 août 2003
01 juil. 2003
publication
Heparan sulfate proteoglycans modulate monocyte migration across cerebral endothelium
Lire plus01 mai 2003
01 mai 2003
publication
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study
Lire plus01 mai 2003
publication
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial
Lire plus01 mars 2003
publication
Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study
Lire plus01 mars 2003
publication
The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis
Lire plus01 janv. 2003
publication
Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection
Lire plus01 janv. 2003
publication
[Late presentation of Wilson’s disease as cirrhosis complicating hepatocellular carcinoma]
Lire plus01 janv. 2003
publication
[New recommendations for diagnosis and virological monitoring of viral hepatitis]
Lire plus01 déc. 2002
01 nov. 2002
01 nov. 2002
publication
Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition?
Lire plus01 nov. 2002
publication
[Hepatitis B virus genotypes: clinical, epidemiological and therapeutic implications]
Lire plus12 oct. 2002
01 oct. 2002
publication
Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels
Lire plus15 sept. 2002
01 sept. 2002
publication
Transmission of group II heteronymous pathways is enhanced in rigid lower limb of de novo patients with Parkinson’s disease
Lire plus01 août 2002
01 juil. 2002
01 juil. 2002
publication
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles
Lire plus01 juin 2002
publication
Interferon-beta directly influences monocyte infiltration into the central nervous system
Lire plus01 juin 2002
publication
Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium
Lire plus31 mai 2002
publication
Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease
Lire plus01 mai 2002
01 avr. 2002
publication
[Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance]
Lire plus01 janv. 2002
publication
Severe evolution of chronic hepatitis C in renal transplantation: a case control study
Lire plus01 janv. 2002
publication
Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy
Lire plus01 déc. 2001
publication
[Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences]
Lire plus01 sept. 2001
publication
Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C
Lire plus01 août 2001
publication
Impact of medical recommendations on alcohol consumption in HCV positive patients
Lire plus01 juil. 2001
publication
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”?
Lire plus01 juin 2001
01 mai 2001
01 mai 2001
publication
The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: a multicentre, prospective study
Lire plus14 avr. 2001
publication
[Management of C virus infection in patients coinfected with HIV treated with antiretroviral agents]
Lire plus01 avr. 2001
21 mars 2001
publication
Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future
Lire plus01 mars 2001
01 févr. 2001
publication
Vaccination of chronic hepatitis B virus carriers with preS2/S envelope protein is not associated with the emergence of envelope escape mutants
Lire plus01 janv. 2001
publication
[Prevention and treatment of viral hepatitis in renal insufficiency conditions]
Lire plus01 janv. 2001
01 nov. 2000
publication
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report
Lire plus14 oct. 2000
08 sept. 2000
publication
Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy?
Lire plus01 sept. 2000
publication
Dilated bile duct in patients receiving narcotic substitution: an early report
Lire plus01 juil. 2000
publication
Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases
Lire plus01 juil. 2000
publication
Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa
Lire plus01 juin 2000
publication
Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C
Lire plus27 mai 2000
publication
HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients
Lire plus15 mai 2000
01 mai 2000
publication
Abnormal reciprocal inhibition between antagonist muscles in Parkinson’s disease
Lire plus01 avr. 2000
publication
Immune therapy of hepatitis B virus (HBV) chronic infection. European experience
Lire plus01 avr. 2000
01 mars 2000
01 févr. 2000
01 janv. 2000
02 nov. 1999
01 oct. 1999
publication
What are the risks involved in kidney transplantation that is probably hepatitis B related
Lire plus01 août 1999
publication
[Coinfection of hepatitis C virus and human immunodeficiency virus and antiretroviral multitherapies]
Lire plus01 juil. 1999
publication
A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France
Lire plus01 juil. 1999
publication
Significance of repeatedly normal aminotransferase activities in HCV-infected patients
Lire plus01 juil. 1999
publication
Epidemiological and virological analysis of couples infected with hepatitis C virus
Lire plus01 juil. 1999
publication
Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens
Lire plus01 mai 1999
01 avr. 1999
publication
[Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin]
Lire plus01 avr. 1999
01 avr. 1999
publication
Handedness-related asymmetry in transmission in a system of human cervical premotoneurones
Lire plus01 avr. 1999
01 mars 1999
publication
Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells
Lire plus01 févr. 1999
publication
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity
Lire plus01 janv. 1999
01 janv. 1999
01 déc. 1998
01 nov. 1998
publication
Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy
Lire plus01 nov. 1998
publication
Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection
Lire plus01 sept. 1998
publication
Impact of co-infection by hepatitis B virus and hepatitis C virus in renal transplantation
Lire plus01 juil. 1998
publication
Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients
Lire plus01 juin 1998
publication
Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users
Lire plus01 mai 1998
publication
ESBRA 1997 Award lecture: relationship between excessive alcohol drinking and viral infections
Lire plus01 mai 1998
publication
Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects
Lire plus01 avr. 1998
15 mars 1998
publication
Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
Lire plus01 mars 1998
publication
[Clinical and Biological Gastroenterology: evaluation of Hepatology division, 1995 to 1997]
Lire plus01 mars 1998
publication
Hepatitis G virus infection in hepatitis C virus-positive patients co-infected or not with hepatitis B virus and/or human immunodeficiency virus
Lire plus01 févr. 1998
01 janv. 1998
publication
[Murderous impulses in two patients with chronic hepatitis C treated with interferon alpha]
Lire plus01 janv. 1998
publication
Characteristics and treatment of hepatitis C virus infection in HIV-coinfected subjects
Lire plus01 oct. 1997
publication
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer
Lire plus01 août 1997
publication
Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa
Lire plus01 mai 1997
publication
Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C
Lire plus15 janv. 1997
publication
Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation
Lire plus01 janv. 1997
publication
[Clinical significance of detection and quantification of hepatitis C virus RNA in hemodialysis: proposal for a rational diagnostic strategy]
Lire plus01 janv. 1997
publication
Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections
Lire plus01 nov. 1996
publication
Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections
Lire plus01 sept. 1996
publication
Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients
Lire plus15 août 1996
27 juil. 1996
publication
The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection
Lire plus27 juin 1996
publication
Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis
Lire plus01 mars 1996
01 janv. 1996
publication
Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients
Lire plus01 janv. 1996
01 janv. 1996
01 janv. 1996
01 janv. 1996
publication
Effectiveness and tolerance of interferon-alpha 2b in the treatment of chronic hepatitis C in haemodialysis patients
Lire plus01 janv. 1996
publication
[Primary non-Hodgkin’s lymphomas of the liver in human immunodeficiency virus infected patients. Three cases]
Lire plus01 janv. 1996
publication
[Liver, biliary tracts and human immunodeficiency virus infection. 2: hepatobiliary complications of AIDS]
Lire plus01 janv. 1996
publication
[Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses]
Lire plus15 oct. 1995
publication
[In situ hybridization for the detection of hepatitis C virus RNA in mononuclear cells of peripheral blood from infected patients]
Lire plus01 sept. 1995
publication
Serum hepatitis C virus (HCV) RNA: a reliable tool for evaluating HCV-related liver disease in anti-HCV-positive blood donors with persistently normal alanine aminotransferase values
Lire plus01 juil. 1995
publication
In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA
Lire plus01 mai 1995
publication
Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients
Lire plus01 mars 1995
01 mars 1995
publication
Value of liver biopsy for the rapid diagnosis of infection in human immunodeficiency virus-infected patients who have unexplained fever and elevated serum levels of alkaline phosphatase or gamma-glutamyl transferase
Lire plus01 févr. 1995
publication
The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients
Lire plus01 févr. 1995
publication
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group
Lire plus01 févr. 1995
publication
Evidence of non-A, non-B, non-C infection in chronic hepatitis by polymerase chain reaction testing for hepatitis B and C viruses
Lire plus01 janv. 1995
01 janv. 1995
publication
Hepatitis C virus infection in hemodialyzed patients and kidney allograft recipients
Lire plus01 janv. 1995
01 janv. 1995
12 nov. 1994
15 sept. 1994
publication
Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study
Lire plus01 sept. 1994
publication
Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients
Lire plus15 août 1994
15 août 1994
30 juil. 1994
26 mars 1994
01 janv. 1994
publication
Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers
Lire plus01 janv. 1994
publication
Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization
Lire plus01 janv. 1994
01 janv. 1994
publication
Effectiveness of adenine arabinoside 5′-monophosphate in kidney transplant recipients with chronic active hepatitis B
Lire plus01 déc. 1993
01 nov. 1993
publication
Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications
Lire plus01 juil. 1993
publication
[Efficacy of immunotherapy with vaccination against hepatitis B virus on virus B multiplication]
Lire plus01 mai 1993
01 avr. 1993
01 févr. 1993
publication
Efficacy of adenine arabinoside 5′-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study
Lire plus14 janv. 1993
publication
Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis
Lire plus01 déc. 1992
publication
Absence of hepatitis delta virus infection in chronic hemodialysis and kidney transplant patients in france
Lire plus01 oct. 1992
publication
Herpesvirus infection of the respiratory tract in patients with alcoholic hepatitis
Lire plus01 sept. 1992
publication
Serum hepatitis C virus RNA and hepatitis B virus DNA in non-A, non-B post-transfusional and sporadic chronic hepatitis
Lire plus01 mai 1992
publication
Enterocytozoon bieneusi infection in acquired immunodeficiency syndrome-related sclerosing cholangitis
Lire plus01 mai 1992
publication
Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation
Lire plus01 avr. 1992
publication
Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus
Lire plus01 mars 1992
27 nov. 1991
publication
[Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation]
Lire plus01 nov. 1991
publication
[Mechanism of action of adenosine on intracellular calcium and platelet aggregation]
Lire plus01 oct. 1991
publication
Hepatic activity and mRNA expression of aspartate aminotransferase isoenzymes in alcoholic and nonalcoholic liver disease
Lire plus15 avr. 1991
01 janv. 1991
publication
Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease
Lire plus01 janv. 1991
publication
An overview of serum mitochondrial aspartate aminotransferase (mAST) activity as a marker of chronic alcohol abuse
Lire plus01 janv. 1991
01 nov. 1990
15 sept. 1990
05 juin 1990
publication
Properties of human liver cytosolic aspartate aminotransferase mRNAs generated by alternative polyadenylation site selection
Lire plus14 avr. 1990
01 avr. 1990
publication
Diagnostic value of serum gamma-glutamyl-transferase activity and mean corpuscular volume in alcoholic patients with or without cirrhosis
Lire plus10 févr. 1990
08 déc. 1989
publication
Regulation of cytosolic aspartate aminotransferase mRNAs in the Fao rat hepatoma cell line by dexamethasone, insulin and cyclic AMP
Lire plus01 sept. 1989
publication
Chromosomal localization of human aspartate aminotransferase genes by in situ hybridization
Lire plus01 sept. 1989
01 janv. 1989
publication
An epidemiological and clinical study of transaminase levels and hepatitis B antibodies in 1,100 blood donors
Lire plus30 déc. 1988
publication
Nucleotide sequence and tissue distribution of the human mitochondrial aspartate aminotransferase mRNA
Lire plus01 janv. 1988
01 déc. 1987
publication
Monoclonal anti-HBs antibodies radioimmunoassay and serum HBV-DNA hybridization as diagnostic tools of HBV infection: relative prevalence among HBsAg-negative alcoholics, patients with chronic hepatitis or hepatocellular carcinomas and blood donors
Lire plus01 oct. 1987
01 févr. 1986
publication
[Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin]
Lire plus01 janv. 1986
01 oct. 1985
publication